News & Analysis on Clinical Trial Services & Contract Research And Development
Drug delivery company Chrono Therapeutics has unveiled a wristwatch-like device for the non-invasive automatic administration of drugs based on the amount and time instructed, thus improving patience compliance.
In-PharmaTechnologist: Focus on India
India is emerging as a powerhouse of pharmaceutical R&D. Backed by a scientist president and with an army of talented scientists, the country now has R&D capacity second only to the US, at one-fifth of the cost.
A new family of objectives from Olympus specifically for Total Internal Reflection Fluorescence Microscopy (TIRFM) can selectively visualise processes and structures of the cell membrane, minimising photo-damage and allowing cells to live longer.
Singapore's Ministry of Trade & Industry (MTI) will commit $7.5bn (€63.1bn) over the next five years to drive R&D growth in key industry areas such as biomedical science and increase national R&D spending to 3 per cent of GDP by 2010.
Swiss outsourcing company Lonza has granted biotechnology firm Genentech a non-exclusive, worldwide license to their Glutamine Synthetase (GS) Gene Expression System which offers better yields, speed and stability in cell protein production, thus...